Ascorbic Acid



Combined with:

Yaz

Indications and Reactions:

Role Indications Reactions
Primary
Small Cell Lung Cancer Metastatic 25.0%
Multiple Myeloma 18.8%
Convulsion 12.5%
Pancreatic Carcinoma Metastatic 12.5%
Asthenia 6.3%
Neoplasm Malignant 6.3%
Small Cell Lung Cancer Stage Unspecified 6.3%
Drug Use For Unknown Indication 3.1%
Migraine 3.1%
Peroneal Muscular Atrophy 3.1%
Product Used For Unknown Indication 3.1%
Convulsion 9.5%
Death 9.5%
Pulmonary Embolism 9.5%
Renal Failure 9.5%
Agitation 4.8%
Cerebrovascular Accident 4.8%
Convulsive Threshold Lowered 4.8%
Drug Interaction 4.8%
Hyperglycaemia 4.8%
Palpitations 4.8%
Reaction To Drug Excipients 4.8%
Renal Tubular Necrosis 4.8%
Urinary Tract Infection 4.8%
Urine Output Decreased 4.8%
Vomiting 4.8%
Weight Increased 4.8%
White Blood Cell Disorder 4.8%
Secondary
Drug Use For Unknown Indication 26.9%
Myelodysplastic Syndrome 13.3%
Product Used For Unknown Indication 12.6%
Acute Myeloid Leukaemia 8.4%
Sedation 4.7%
Multiple Myeloma 4.6%
Pharyngitis 4.1%
Prostate Cancer Metastatic 4.0%
Hypertension 3.6%
Antibiotic Therapy 2.5%
Antibiotic Level 2.1%
Vitamin Supplementation 2.1%
Nasopharyngitis 1.9%
Anaesthesia 1.5%
Bipolar Disorder 1.4%
Myelofibrosis 1.4%
Polyuria 1.4%
Intentional Overdose 1.3%
Muscle Relaxant Therapy 1.1%
Pain 1.1%
Toxic Epidermal Necrolysis 13.2%
Pyrexia 11.3%
Vomiting 9.4%
Anaphylactic Reaction 5.7%
Off Label Use 5.7%
Pneumonia 5.7%
Ulcerative Keratitis 5.7%
Cytolytic Hepatitis 4.7%
Tubulointerstitial Nephritis 4.7%
Cataract 3.8%
Renal Failure Acute 3.8%
Swollen Tongue 3.8%
Electrocardiogram Qt Prolonged 2.8%
Intentional Overdose 2.8%
Malaise 2.8%
Melaena 2.8%
Nasopharyngitis 2.8%
Pericardial Effusion 2.8%
Pneumothorax 2.8%
Pulmonary Valve Stenosis 2.8%
Concomitant
Product Used For Unknown Indication 29.6%
Drug Use For Unknown Indication 23.6%
Hypertension 5.6%
Osteoporosis 4.4%
Pain 4.1%
Rheumatoid Arthritis 4.0%
Vitamin Supplementation 3.8%
Prophylaxis 3.3%
Depression 2.4%
Supplementation Therapy 2.3%
Blood Cholesterol Increased 2.1%
Gastrooesophageal Reflux Disease 1.8%
Contraception 1.8%
Osteopenia 1.7%
Medical Diet 1.7%
Crohn's Disease 1.6%
Diabetes Mellitus 1.6%
Asthma 1.5%
Multiple Sclerosis 1.5%
Anxiety 1.4%
Vomiting 12.5%
Weight Decreased 9.5%
Weight Increased 6.7%
Pain 6.2%
Flushing 5.6%
Urinary Tract Infection 5.4%
Pulmonary Embolism 4.5%
Nausea 4.4%
Pain In Extremity 4.4%
Pruritus 4.4%
Drug Ineffective 4.2%
Pneumonia 4.2%
Rash 4.1%
Dyspnoea 3.8%
Death 3.7%
Pyrexia 3.5%
White Blood Cell Count Decreased 3.3%
Headache 3.3%
Vision Blurred 3.1%
Urticaria 2.9%
Interacting
Product Used For Unknown Indication 41.8%
Prophylaxis 9.1%
Systemic Candida 7.3%
Atrial Fibrillation 3.6%
Drug Use For Unknown Indication 3.6%
Headache 3.6%
Hypertension 3.6%
Lung Neoplasm Malignant 3.6%
Renal Failure Chronic 3.6%
Anal Candidiasis 1.8%
Anticoagulant Therapy 1.8%
Cough 1.8%
Iron Deficiency 1.8%
Ischaemic Heart Disease Prophylaxis 1.8%
Liver Transplant 1.8%
Lower Respiratory Tract Infection 1.8%
Pneumonia 1.8%
Thyroid Disorder 1.8%
Tremor 1.8%
Venous Thrombosis 1.8%
International Normalised Ratio Increased 17.6%
Drug Interaction 11.8%
Gastrointestinal Infection 11.8%
Haemorrhagic Diathesis 11.8%
Blood Creatinine Increased 5.9%
Cervical Incompetence 5.9%
Fatigue 5.9%
Inhibitory Drug Interaction 5.9%
Performance Status Decreased 5.9%
Prostatic Calcification 5.9%
Tremor 5.9%
Vomiting 5.9%